In vitro binding study for sevelamer carbonate for Europe submission [Regulatives / Guidelines]

posted by jansari  – India, 2023-02-24 16:24 (451 d 18:24 ago) – Posting: # 23474
Views: 1,980

Dear Divyen

❝ ❝ ❝ they given the reference of following of guidance documents of Europe:: Guideline for locally applied , locally acting product in Gestrointestinal trac(CPMP/EWP/239/95Rev.1,Cor.1*) and this guidance documents given the acceptance limit as +- 10percentage..

❝ Read the sentence again: In vitro similarity should be assessed with a ±10% acceptance range, unless otherwise justified.

we were already given justification based on this sentence.and explain that our study is passing within T/R ratio as per acceptance limit 0.9 to 1.1...but they are not accepting the same and again raised the now we are repeating the same study ,.
can I have your mail ID ?so I can detailed out the study detail which results we obtained in the study..and what exactly regulatory asked?

❝ Kindly refer Calcium acetate USFDA PSG.


Awaiting for your positive reply..:-


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
 Admin contact
23,034 posts in 4,835 threads, 1,647 registered users;
30 visitors (0 registered, 30 guests [including 5 identified bots]).
Forum time: 11:48 CEST (Europe/Vienna)

Give me a fruitful error any time, full of seeds, bursting with its own corrections.
You can keep your sterile truth for yourself.    Vilfredo Pareto

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz